Steady-state plasma concentrations of alprenolol in man
- PMID: 4419005
- DOI: 10.1007/BF00558205
Steady-state plasma concentrations of alprenolol in man
Similar articles
-
Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.Eur J Clin Pharmacol. 1976 Jun 15;10(2):85-8. doi: 10.1007/BF00609464. Eur J Clin Pharmacol. 1976. PMID: 9292
-
Alprenolol in angina pectoris. A comparative study of the tablet form and slow-release formulation.Med J Aust. 1975 Oct 25;2(17):668-73. Med J Aust. 1975. PMID: 1107769 Clinical Trial.
-
Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.Br Heart J. 1973 Mar;35(3):320-33. doi: 10.1136/hrt.35.3.320. Br Heart J. 1973. PMID: 4632566 Free PMC article. Clinical Trial. No abstract available.
-
Beta-adrenergic receptor blocking drugs in angina pectoris.Drugs. 1974;7(1):55-84. doi: 10.2165/00003495-197407010-00005. Drugs. 1974. PMID: 4151695 Review. No abstract available.
-
[Therapy and differential therapy with beta sympathicolytic drugs].Med Klin. 1975 Oct 17;70(42):1682-7. Med Klin. 1975. PMID: 241898 Review. German. No abstract available.
Cited by
-
Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.Br J Clin Pharmacol. 1980 Aug;10(2):121-6. doi: 10.1111/j.1365-2125.1980.tb01728.x. Br J Clin Pharmacol. 1980. PMID: 6252915 Free PMC article. Clinical Trial.
-
Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.Eur J Clin Pharmacol. 1976 Jun 15;10(2):85-8. doi: 10.1007/BF00609464. Eur J Clin Pharmacol. 1976. PMID: 9292
-
Pharmacokinetics and pharmacodynamics of warfarin at steady state.Br J Clin Pharmacol. 1979 Sep;8(3):243-7. doi: 10.1111/j.1365-2125.1979.tb01009.x. Br J Clin Pharmacol. 1979. PMID: 497091 Free PMC article.
-
Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.J Pharmacokinet Biopharm. 1977 Jun;5(3):193-205. doi: 10.1007/BF01065395. J Pharmacokinet Biopharm. 1977. PMID: 881641 No abstract available.
-
Single and multiple dose pharmacokinetics of pindolol.Eur J Clin Pharmacol. 1978 Mar 17;13(1):13-6. doi: 10.1007/BF00606675. Eur J Clin Pharmacol. 1978. PMID: 639828
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources